Gessner, PK; Godse, DD; Krull, AH; McMullan, JM. Structure-activity relationships among 5-methoxy-N:N-dimethyltryptamine, 4-hydroxy-N:N-dimethyltryptamine (psilocin) and other substituted tryptamines. Life Sci., 1 Mar 1968, 7 (5), 267–277. 362 kB. https://doi.org/10.1016/0024-3205(68)90200-2 #7MeO-DMT
Lyon, RA; Titeler, M; Seggel, MR; Glennon, RA. Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens. Eur. J. Pharmacol., 19 Jan 1988, 145 (3), 291–297. 533 kB. https://doi.org/10.1016/0014-2999(88)90432-3
Glennon, RA; Dukat, M; Grella, B; Hong, S; Costantino, L; Teitler, M; Smith, C; Egan, C; Davis, K; Mattson, MV. Binding of β-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors. Drug Alcohol Depend., 1 Aug 2000, 60 (2), 121–132. 276 kB. https://doi.org/10.1016/S0376-8716(99)00148-9
Glennon, RA; Gessner, PK. Serotonin receptor binding affinities of tryptamine analogues. J. Med. Chem., 1 Jan 1979, 22 (4), pp 428–432. 731 kB. https://doi.org/10.1021/jm00190a014 #25
Gornez-Jeria, JS; Morales-Lagos, D; Cassels, BK; Saavedra-Aguilar, JC. Electronic structure and serotonin receptor binding affinity of 7-substituted tryptamines QSAR of 7-substituted tryptamines. Quant. Struct.-Act. Relat., 1 Jan 1986, 5 (4), 153–157. 577 kB. https://doi.org/10.1002/qsar.19860050404 #4
Glennon, RA; Young, R; Rosecrans, JA; Kallman, MJ. Hallucinogenic agents as discriminative stimuli: A correlation with serotonin receptor affinities. Psychopharmacology, 1 May 1980, 68 (2), 155–158. 395 kB. https://doi.org/10.1007/BF00432133 #7-OMe DMT
Glennon, RA; Rosecrans, JA. Indolealkylamine and phenalkylamine hallucinogens: A brief overview. Neurosci. Biobehav. Rev., 1 Jan 1982, 6 (4), 489–497. 895 kB. https://doi.org/10.1016/0149-7634(82)90030-6 #3i
Gupta, SP; Singh, P; Bindal, MC. QSAR studies on hallucinogens. Chem. Rev., 1 Dec 1983, 83 (6), 633–649. 2.8 MB. https://doi.org/10.1021/cr00058a003 #86
Klein, MT; Dukat, M; Glennon, RA; Teitler, M. Toward selective drug development for the human 5-hydroxytryptamine 1E receptor: A comparison of 5-hydroxytryptamine 1E and 1F receptor structure-affinity relationships. J. Pharmacol. Exp. Ther., 1 Jun 2011, 337 (3), 860–267. 1.7 MB. https://doi.org/10.1124/jpet.111.179606 #32
4-HO-MET · 4-Hydroxy-N-methyl-N-ethyltryptamine
5-MeO-DMT · 5-Methoxy-N,N-dimethyltryptamine · N,N,O-TMS · OMB
5-MeO-α,N-DMT · 5-MeO-α-methyl-NMT · 5-Methoxy-α-methyl-N-methyltryptamine · α,N,O-TMS
1-MeO-DMT · 1-Methoxy-N,N-dimethyltryptamine
1-Methyl-4-HO-DMT · 1-Methyl-4-hydroxy-N,N-dimethyltryptamine · 1-Methylpsilocin · CMY
5-MeO-AET · 5-Methoxy-α-ethyltryptamine
4-MeO-DMT · 4-Methoxy-N,N-dimethyltryptamine · PSOM
6-MeO-DMT · 6-Methoxy-N,N-dimethyltryptamine
5-HO-TMT+ · 5-HTQ · 5-Hydroxy-N,N,N-trimethyltryptamine+
5-MeO-NET · 5-Methoxy-N-ethyltryptamine
2-Methyl-4-HO-DMT · 2-Methyl-4-hydroxy-N,N-dimethyltryptamine · 2-Methylpsilocin
4-HO-α-methyl-DMT · 4-Hydroxy-α-methyl-N,N-dimethyltryptamine · α-Methylpsilocin
1-Methyl-5-HO-DMT · 1-Methyl-5-hydroxy-N,N-dimethyltryptamine · 1-Methylbufotenine
5-PrO-T · 5-Propoxytryptamine
5-IPrO-T · 5-Isopropoxytryptamine
5-EtO-NMT · 5-Ethoxy-N-methyltryptamine
5-HO-NIPT · 5-Hydroxy-N-isopropyltryptamine
6-MeO-iso-DMT · 6-Methoxy-N,N-dimethyl-isotryptamine
5-MeO-iso-DMT · 5-Methoxy-N,N-dimethyl-isotryptamine
4-Methyl-5-HO-DMT · 4-Methyl-5-hydroxy-N,N-dimethyltryptamine · 4-Methylbufotenin
Ritalinamide · Ritalinic acid amide
4-HO-NIPT · 4-Hydroxy-N-isopropyltryptamine
5-EtO-AMT · 5-Ethoxy-α-methyltryptamine
7-MeO-iso-DMT · 7-Methoxy-N,N-dimethyl-isotryptamine
4-MeO-iso-DMT · 4-Methoxy-N,N-dimethyl-isotryptamine
4-HO-TMT+ · 4-Hydroxy-N,N,N-trimethyltryptamine+
7-Methyl-4-HO-DMT · 7-Methyl-4-hydroxy-N,N-dimethyltryptamine · 7-Methylpsilocin
5-Methyl-4-HO-DMT · 5-Methyl-4-hydroxy-N,N-dimethyltryptamine · 5-Methylpsilocin
7-MeO-NET · 7-Methoxy-N-ethyltryptamine